Scarica l'app Stockscreener
10.28
20.52%
1.75
Dopo l'orario di chiusura:
10.20
-0.08
-0.78%
Precedente Chiudi:
$8.53
Aprire:
$8.58
Volume 24 ore:
3.16M
Relative Volume:
3.17
Capitalizzazione di mercato:
$911.60M
Reddito:
$73.48M
Utile/perdita netta:
$-108.30M
Rapporto P/E:
-4.5689
EPS:
-2.25
Flusso di cassa netto:
$-67.17M
1 W Prestazione:
+19.40%
1M Prestazione:
+75.13%
6M Prestazione:
+212.46%
1 anno Prestazione:
+115.06%
Intervallo 1D:
$8.50
$10.35
Intervallo di 1 settimana:
$7.78
$10.35
Portata 52W:
$2.8262
$10.35
Personalis Inc Stock (PSNL) Company Profile
Nome
Personalis Inc
Settore
Industria
Telefono
650-752-1300
Indirizzo
6600 DUMBARTON CIRCLE, FREMONT, CA
Confronta PSNL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
10.28 | 728.93M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
536.78 | 198.56B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
210.92 | 147.61B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
637.34 | 50.96B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
141.10 | 39.13B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
205.75 | 34.81B | 15.70B | 1.24B | 2.01B | 6.9036 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-05-15 | Iniziato | Guggenheim | Buy |
| 2025-03-17 | Iniziato | Craig Hallum | Buy |
| 2023-02-06 | Aggiornamento | Needham | Hold → Buy |
| 2022-01-07 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2021-11-05 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2021-11-03 | Downgrade | Needham | Buy → Hold |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-09-20 | Reiterato | Needham | Buy |
| 2021-05-06 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2021-01-28 | Iniziato | Truist | Buy |
| 2021-01-04 | Downgrade | BofA Securities | Buy → Neutral |
| 2020-11-12 | Reiterato | Needham | Buy |
| 2020-11-06 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-10-19 | Iniziato | Citigroup | Buy |
| 2020-10-08 | Iniziato | BTIG Research | Buy |
| 2020-08-27 | Iniziato | H.C. Wainwright | Buy |
| 2020-08-18 | Iniziato | Needham | Buy |
| 2019-09-26 | Aggiornamento | BofA/Merrill | Neutral → Buy |
| 2019-07-15 | Iniziato | BofA/Merrill | Neutral |
| 2019-07-15 | Iniziato | Cowen | Outperform |
| 2019-07-15 | Iniziato | Morgan Stanley | Overweight |
| 2019-07-15 | Iniziato | Oppenheimer | Outperform |
Mostra tutto
Personalis Inc Borsa (PSNL) Ultime notizie
Will breakout in Personalis Inc. lead to full recoveryOil Prices & Capital Efficient Trading Techniques - newser.com
What momentum shifts mean for Personalis Inc.July 2025 Breakouts & Technical Buy Zone Confirmations - newser.com
Analyzing Personalis Inc. with risk reward ratio chartsIPO Watch & Verified Entry Point Detection - newser.com
Personalis rises as blood test detects lung cancer months before imaging - TradingView
Personalis announces new data from a landmark lung cancer trial utilizing ultrasensitive MRD testing - MarketScreener
Personalis Announces New Data from a Landmark Lung Cancer Trial Utilizing Ultrasensitive MRD Testing - Yahoo Finance
Will Personalis Inc. benefit from macro trendsJuly 2025 Earnings & Reliable Trade Execution Plans - newser.com
Will Personalis Inc. see short term momentumJuly 2025 Drop Watch & Fast Entry High Yield Stock Tips - newser.com
Will Personalis Inc. stock see PE expansion2025 Price Momentum & Verified Swing Trading Watchlists - newser.com
Will Personalis Inc. stock gain from government policies2025 Market Trends & High Accuracy Buy Signal Tips - newser.com
Why Personalis Inc. stock remains on watchlistsJuly 2025 Outlook & Fast Entry High Yield Tips - newser.com
Why Personalis Inc. stock could be next big winnerJuly 2025 Big Picture & AI Powered Buy/Sell Recommendations - newser.com
Using Python tools to backtest Personalis Inc. strategiesMarket Performance Report & AI Powered Buy and Sell Recommendations - newser.com
Is Personalis Inc 04X a good long term investmentTrendline Breakouts & Low Cost Market Strategies - earlytimes.in
Is Personalis Inc. stock ready for breakout2025 Biggest Moves & AI Powered Buy/Sell Recommendations - newser.com
Is Personalis Inc. trending in predictive chart modelsWeekly Gains Summary & Growth Focused Stock Reports - newser.com
Visual trend scoring systems applied to Personalis Inc.Weekly Risk Report & High Yield Equity Trading Tips - newser.com
Real time scanner hits for Personalis Inc. explainedCPI Data & Safe Capital Growth Tips - newser.com
Price momentum metrics for Personalis Inc. explainedQuarterly Growth Report & Verified Trade Idea Suggestions - newser.com
Analyzing net buyer seller activity in Personalis Inc.Weekly Stock Summary & Long-Term Growth Stock Strategies - newser.com
Personalis, Inc. (NASDAQ:PSNL) Given Consensus Recommendation of “Moderate Buy” by Analysts - Defense World
How to monitor Personalis Inc. with trend dashboardsWeekly Market Outlook & Precise Buy Zone Tips - newser.com
Forecasting Personalis Inc. price range with options dataEarnings Growth Report & Safe Capital Growth Plans - newser.com
Personalis, Inc. Hits New 52-Week High of $8.70, Up 557.58% - Markets Mojo
Understanding Personalis Inc.’s price movementPortfolio Return Report & Community Trade Idea Sharing - newser.com
What MACD signals say about Personalis Inc.Quarterly Trade Report & Weekly Momentum Picks - newser.com
Personalis (NASDAQ:PSNL) Reaches New 1-Year HighHere's What Happened - MarketBeat
Head-To-Head Review: Parnell Pharmaceuticals (OTCMKTS:PARNF) versus Personalis (NASDAQ:PSNL) - Defense World
Personalis (NASDAQ:PSNL) surges 13% this week, taking three-year gains to 153% - simplywall.st
What analysts say about Personalis Inc 04X stockMarket Timing Techniques & Free Get High Impact Recommendations - earlytimes.in
Exit strategy if you’re trapped in Personalis Inc.Market Movement Recap & Daily Profit Focused Stock Screening - newser.com
What indicators show strength in Personalis Inc.Market Performance Recap & Advanced Technical Signal Analysis - newser.com
Personalis Inc Azioni (PSNL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Personalis Inc Azioni (PSNL) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Tachibana Aaron | CFO AND COO |
Jul 28 '25 |
Sale |
6.57 |
641 |
4,211 |
164,458 |
| Tachibana Aaron | CFO AND COO |
May 16 '25 |
Sale |
4.95 |
1,291 |
6,390 |
165,099 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
May 16 '25 |
Sale |
4.95 |
1,675 |
8,291 |
64,200 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
May 16 '25 |
Sale |
4.95 |
910 |
4,504 |
124,957 |
| Tachibana Aaron | CFO AND COO |
Jan 28 '25 |
Sale |
5.79 |
708 |
4,099 |
166,390 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jan 28 '25 |
Sale |
5.79 |
519 |
3,005 |
123,367 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Dec 16 '24 |
Sale |
3.82 |
4,834 |
18,466 |
123,886 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
Dec 16 '24 |
Sale |
3.82 |
1,513 |
5,780 |
65,875 |
| Tachibana Aaron | CFO AND COO |
Dec 16 '24 |
Sale |
3.82 |
6,865 |
26,224 |
167,098 |
| Tachibana Aaron | CFO AND COO |
Nov 18 '24 |
Sale |
3.79 |
1,307 |
4,954 |
173,963 |
0.74%
0.28%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):